VYNE Therapeutics's total assets for Q4 2024 were $66.91M, a decrease of -12.20% from the previous quarter. VYNE total liabilities were $14.82M for the fiscal quarter, a 17.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.